Founder, President, CEO

András is the founder of Clinch Biosciences and Motorpharma Ltd., and the principal investigator of the Motor Pharmacology Research Group of the Hungarian Academy of Sciences at the Eötvös University (ELTE) in Budapest. The Málnási laboratory has been one of the flagships of actin-myosin motor protein research for the last two decades supported by international grants including Wellcome Trust, EMBO, Howard Hughes and ERC. Andras was a Review Committee member of the Life Sciences panel at ERC, and was rewarded by several national and international prizes including the Innovative Researcher Award at ELTE and the Hungarian Academy Award.

András is Professor of Biochemistry at ELTE and he is a Doctor of the Hungarian Academy of Sciences. He has more than 60 scientific publications, all in the most prestigious journals, including Science, Cell, Nature publishing group journals and Proceedings of the National Academy of Sciences (PNAS), with several thousand citations, and he is inventor in more than 10 patents.

András was the Principal Investigator and team leader of the development of MPH-220, a first-in-class selective muscle relaxant, which has excellent safety and tolerability in Phase 1, and advances to Phase 2a. András led the negotiation with Aditum Bio on the formation of Motric Bio for the clinical development of MPH-220, now MTR-601. András is a Board Member of Motric Bio.

Founder, CSO

Máté is a biochemist with over 20 years basic research background in motor enzymology and with 7 years of preclinical drug development experience.  Under his leadership, a vast myosin inhibitor portfolio has been developed hallmarked by the first-in-class muscle relaxant, MTR-601 (MPH-220), which has completed Phase 1 clinical trial and is currently in Phase 2a nder the control of Motric Bio. In his postdoctoral period Mate worked as senior research fellow at Eotvos University and at University of California, Davis, in the framework of two Marie Curie International Fellowships. 

Mate received his PhD in structural biochemistry at Eotvos Lorand University, Hungary. He received numerous prizes recognizing his excellence in science such as the Promising Researcher and subsequently the Innovative Researcher at Eotvos University, and he obtained the QP-Hungarian Academy of Sciences Academic Excellence Award for his outstanding achievements in applied sciences.

Founder, Senior Researcher

Balázs Jelinek has a PhD in structural biochemistry from Eotvos Lorand University, Hungary. In András Málnási-Csizmadia’s cutting edge laboratory Balázs became an expert life science project manager, accumulating by now almost 20 years of experience in research management, including the operational and financial control of ERC, NIH, HHMI, EMBO and large consortial research projects. He was a key contributor in the consecutive projects from discovery research to preclinical development that resulted in the first-in-class muscle relaxant MPH-220, which has proved safe and tolerable in Phase 1 clinical trial in and currently in Phase 2a in the US. Successful licensing of MPH-220 to Motric Bio, Inc. was implemented through Motorpharma Ltd., of which Balázs is a co-founder and CEO.

 General Counsel, Treasurer

Anna had a versatile education including MSc both in Biology and Biomedical Engineering, PhD in Molecular Biology and a higher-level course in Industrial Property Law. During her visiting studentship in Cambridge (UK) she was also involved in entrepreneurial skill sessions and networking events. She managed a successful ERC PoC grant and created the business plan for the first inventions originating from the lab of András Málnási-Csizmadia. As CEO of Motorpharma Ltd., she clinched in-licensing and out-licencing deals for the company and managed the corresponding patent portfolio.

VP, Regulatory Affairs and CMC

Gizella is a chemical engineer specialized in pharmaceutical engineering. Gizella worked for more than 20 years in big pharma at Egis Pharmaceuticals PLC, a subsidiary of Servier, as Technical Documentation and Pharmaceutical  Registry Associate. She was responsible for writing, compiling and regulatory filings of Drug Master Files, Registars and Technical Packages, and has extensive experience in communication with regulatory authorities at FDA, EMA, Russia, China, Japan, India and Brazil.